19-8731553-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004699.3(OR2Z1):c.525T>A(p.Asp175Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000452 in 1,614,074 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004699.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR2Z1 | NM_001004699.3 | c.525T>A | p.Asp175Glu | missense_variant | 3/3 | ENST00000641125.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR2Z1 | ENST00000641125.1 | c.525T>A | p.Asp175Glu | missense_variant | 3/3 | NM_001004699.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152062Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000994 AC: 25AN: 251486Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135918
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1461894Hom.: 0 Cov.: 33 AF XY: 0.0000234 AC XY: 17AN XY: 727248
GnomAD4 genome AF: 0.000191 AC: 29AN: 152180Hom.: 0 Cov.: 32 AF XY: 0.000282 AC XY: 21AN XY: 74400
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 15, 2021 | The c.525T>A (p.D175E) alteration is located in exon 1 (coding exon 1) of the OR2Z1 gene. This alteration results from a T to A substitution at nucleotide position 525, causing the aspartic acid (D) at amino acid position 175 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at